Theralink Technologies Inc

OTC Pink - Current Information:THERUnited States

Theralink Technologies, Inc. is a proteomics-based, precision medicine company. The Company, through its phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. In addition to the Company’s first assay for advanced breast cancer, the Company is working on a second assay, which is pan-tumor for solid tumors across multiple tumor types, such as ovarian, endometrial, pancreatic, liver, head and neck, colorectal, lung, and prostate, among others. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both Food and Drug Administration (FDA)-approved and investigational drug treatments. The Company’s applications are across multiple cancer types, including but not limited to, breast, non-small cell lung, colorectal and pancreatic.

Contact Information

Headquarters

8000 INNOVATION PARK, DR, BATON ROUGEBATON ROUGE, LA, United States 70820

Phone

225-578-7555

Fax

---

Executives

Chairman of the Board

Jeffrey Busch

President, Chief Executive Officer, Chief Operating Officer

Faith Zaslavsky

Chief Financial Officer, Director

Andrew Kucharchuk

Chief Medical Officer, Director

Michael Ruxin

Director

Yvonne Fors